Fulcrum Therapeutics
FULC
110 hedge funds and large institutions have $648M invested in Fulcrum Therapeutics in 2021 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 41 increasing their positions, 23 reducing their positions, and 24 closing their positions.
83% more call options, than puts
Call options by funds: $2.24M | Put options by funds: $1.22M
78% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 23
42% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 24
9% more funds holding
Funds holding: 101 → 110 (+9)
1.65% more ownership
Funds ownership: 92.98% → 94.63% (+1.6%)
36% less capital invested
Capital invested by funds: $1.01B → $648M (-$362M)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Holocene Advisors
New York
|
+$17.1M |
| 2 |
LGM
Logos Global Management
San Francisco,
California
|
+$13.6M |
| 3 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$11.2M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$10.7M |
| 5 |
SCM
Suvretta Capital Management
New York
|
+$8.59M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
-$44M |
| 2 |
BC
Boxer Capital
San Diego,
California
|
-$35.3M |
| 3 |
TGI
TRV GP III
Boston,
Massachusetts
|
-$19.8M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$9.68M |
| 5 |
N
Natixis
Paris,
France
|
-$7.11M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
126
Jacobs Levy Equity Management
Florham Park,
New Jersey
| – | -$211K | -7,487 | Closed |
|
|
PFA
127
Paradigm Financial Advisors
Des Peres,
Missouri
| – | -$208K | -7,375 | Closed |
|
128
Group One Trading
Chicago,
Illinois
| – | -$98.5K | -4,973 | Closed |
|
129
Blackstone Inc
New York
| – | -$134K | -4,758 | Closed |
|
|
PCM
130
Penserra Capital Management
Orinda,
California
| – | -$26K | -925 | Closed |
|
131
Osaic Holdings
Scottsdale,
Arizona
| – | -$8K | -300 | Closed |
|
132
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$2K | -71 | Closed |
|
133
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | +$59 | +3 | New |
|
|
EI
134
Ellevest Inc
New York
| – | +$396 | +20 | +500% |
|
FULC Hedge Fund Activity: Q4 2021 in Review
110 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Fulcrum Therapeutics (FULC) for Q4 2021, worth a combined $648M — down 36% from $1.01B a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new FULC positions and 24 closed out — a net gain of 10 holders — while 41 added to existing stakes and 23 trimmed.
The largest buyer was Holocene Advisors, opening a new position worth an estimated $17.1M. The largest seller was Cowen and Company, exiting entirely with an estimated $44M sold.
- 110 institutional investors held Fulcrum Therapeutics (FULC) as of Q4 2021, up from 101 in Q3 2021.
- Funds reported $648M of Fulcrum Therapeutics stock for Q4 2021, down 36% quarter-over-quarter.
- 34 funds opened new Fulcrum Therapeutics positions in Q4 2021 and 24 closed out, a net change of +10 holders.
- The largest Fulcrum Therapeutics buyer in Q4 2021 was Holocene Advisors, an estimated $17.1M added.
- The largest Fulcrum Therapeutics seller in Q4 2021 was Cowen and Company, an estimated $44M sold.
Based on aggregated 13F filings for Q4 2021.